Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Final Results of Phase 1 MMRC Trial of Selinexor, Carfilzomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM)

Andrzej Jakubowiak, MDPhD, Jagoda Jasielec, MD, Cara A. Rosenbaum, MD, Craig E. Cole, MD, Ajai Chari, MD, Jennifer Nam, Erica Severson, Leonor A Stephens, PhD, Kathryn McDonnell, Shaun Rosebeck, PhD, Todd Zimmerman, MD, Theodore Karrison, PhD, Jeffrey Zonder, MD

Blood (2016) 128 (22): 973.

DOI: https://doi.org/10.1182/blood.V128.22.973.973

Published: 2016

Journal Articles

Phase II Study of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas: Final Analysis of NCI 8309

Justin Kline, MD, Aaron P. Rapoport, MD, Adam M. Petrich, MD, Kenneth S. Cohen, MD, Sachdev P. Thomas, MD, Sreenivasa Nattam, MD, Krishna Rao, MD, Bethany Sleckman, MD, Walter Stadler, MD, Theodore Karrison, PhD, Sonali M. Smith, MD

Blood (2016) 128 (22): 4147.

DOI: https://doi.org/10.1182/blood.V128.22.4147.4147

Published: 2016

Journal Articles

Prospective Phase I Multi-Center Trial Incorporating Lenalidomide (LEN) into Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Patients with Double Hit (DHL) or Double Expressing (DEL) Lymphomas: Final Results

Chadi Nabhan, MD MBA, FACP, Theodore Karrison, PhD, Justin Kline, Kenneth Cohen, MD, Michael R. Bishop, MD, Reem Karmali, MD MS, Aaron P. Rapoport, MD, Parameswaran Venugopal, MD, James Wade, MD, Paul Fishkin, MD, Sonali M. Smith, MD

Blood (2016) 128 (22): 4191.

DOI: https://doi.org/10.1182/blood.V128.22.4191.4191

Published: 2016

Journal Articles

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Natalie Galanina, MD, Sonali M. Smith, MD, Chuanhong Liao, PhD, Adam M. Petrich, MD, Bernadette Libao, Ron Gartenhaus, MD, Jason R Westin, MD, Kenneth S. Cohen, MD, James Knost, MD, Walter Stadler, MD, Austin Doyle, MD, Theodore Karrison, PhD, Leo I. Gordon, MD, Andrew M Evens, DO, MS

Blood (2015) 126 (23): 3990.

DOI: https://doi.org/10.1182/blood.V126.23.3990.3990

Published: 2015

Journal Articles

Phase 1 MMRC Trial of Selinexor, Carfilzomib (CFZ), and Dexamethasone (DEX) in Relapsed and Relapsed/Refractory Multiple Myeloma (RRMM)

Andrzej Jakubowiak, MD PhD, Jagoda Jasielec, MD, Cara A. Rosenbaum, MD, Jeffrey A Zonder, MD, Craig E. Cole, MD, Ajai Chari, MD, Jennifer Nam, Leonor A Stephens, PhD, Kathryn McDonnell, Rebecca Uribe, Shaun Rosebeck, PhD, Tami Rashal, MD, Hagop Youssoufian, MD, Sarah Henry, Sharon Shacham, Michael Kauffman, MD PhD, Todd Zimmerman, MD, Theodore Karrison, PhD

Blood (2015) 126 (23): 4223.

DOI: https://doi.org/10.1182/blood.V126.23.4223.4223

Published: 2015

Journal Articles

Haploinsufficiency of del(5q) genes, Egr1 and Apc , cooperate with Tp53 loss to induce acute myeloid leukemia in mice

Angela Stoddart, Anthony A. Fernald, Jianghong Wang, Elizabeth M. Davis, Theodore Karrison, John Anastasi, Michelle M. Le Beau

Blood (2014) 123 (7): 1069–1078.

DOI: https://doi.org/10.1182/blood-2013-07-517953

Published: 2014

Includes: Supplemental data

Journal Articles

Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc

Angela Stoddart, Jianghong Wang, Anthony A. Fernald, Theodore Karrison, John Anastasi, Michelle M. Le Beau

Blood (2014) 123 (2): 228–238.

DOI: https://doi.org/10.1182/blood-2013-05-506568

Published: 2014

Includes: Supplemental data

Journal Articles

Retroviral Insertional Mutagenesis In Egr1 +/- mice, Haploinsufficient For a Human Del(5q) Myeloid Leukemia Gene, Develop Myeloid Neoplasms With Proviral Insertions In Genes Syntenic To Human 5q

Angela Stoddart, PhD, Anthony Fernald, Rachel Joy Bergerson, PhD, Jianghong Wang, M.D., Megan E. McNerney, MD, PhD, Theodore Karrison, Ph.D., John Anastasi, MD, Elizabeth Bartom, Ph.D., Aaron G. Sarver, Ph.D., Zhijian Qian, PhD, Linda Wolff, PhD, David A. Largaespada, PhD, Michelle M. le Beau, PhD

Blood (2013) 122 (21): 1275.

DOI: https://doi.org/10.1182/blood.V122.21.1275.1275

Published: 2013

Journal Articles

Identification of High Risk HLA Class I Amino Acid Substitutions in Hematopoietic Stem Cell Transplantation.

Susana R Marino, MD, PhD, Sang M Lee, PhD, T Andrew Binkowski, PhD, Michael D Haagenson, MS, Martin Maiers, PhD, Stephen Spellman, MBS, Koen van Besien, MD, Stephanie J Lee, MD, MPH, Theodore Karrison, PhD, Andrew Artz, MD MS

Blood (2012) 120 (21): 3050.

DOI: https://doi.org/10.1182/blood.V120.21.3050.3050

Published: 2012

Journal Articles

Therapy-Related Myeloid Neoplasms (t-MN) in 71 Patients Following Radiation Therapy (RT) Only,

Richard J Lin, M.D., Smita Joshi, M.D., Michelle M. Le Beau, PhD, Howard Weiner, Peggy Green, RN, Theodore Karrison, Ph.D., Richard A. Larson, MD

Blood (2011) 118 (21): 3522.

DOI: https://doi.org/10.1182/blood.V118.21.3522.3522

Published: 2011

Journal Articles

Allogeneic Hematopoietic Cell Transplantation From Combined Haploidentical Family Members and Unrelated Cord Blood (CB) Can Benefit High Risk Patients Lacking HLA-Identical Donors.

Elizabeth Shima Rich, MD, PhD, Andrew Artz, MD, MS, Theodore Karrison, Ph.D., Lucy A Godley, MD, PhD, Olatoyosi Odenike, MD, Loren Joseph, MD, Justin Kline, MD, Vu H. Nguyen, MD, Guadalupe Martinez, BS, Paula del Cerro, RN, Lisa Pape, RN, Linda Schroeder, RN, Scott Allen, BA, Sarah Horowitz, BA, John Cunningham, MD, Richard A. Larson, MD, Wendy Stock, MD, Amittha Wickrema, PhD, Koen van Besien, MD

Blood (2009) 114 (22): 3378.

DOI: https://doi.org/10.1182/blood.V114.22.3378.3378

Published: 2009

Journal Articles

Preliminary Results of Combined Haploidentical-Cord Blood Transplantation for Patients Lacking HLA Identical Donors

Elizabeth Shima Rich, MD, PhD, Andrew Artz, MD, MS, Theodore Karrison, PhD, Amittha Wickrema, PhD, Loren Joseph, PhD, Lucy Godley, MD, PhD, Olatoyosi Odenike, MD, Justin Kline, MD, Paula del Cerro, RN, John M Cunningham, MD, Richard A. Larson, MD, Wendy Stock, MD, Koen van Besien, MD

Blood (2008) 112 (11): 3015.

DOI: https://doi.org/10.1182/blood.V112.11.3015.3015

Published: 2008

Journal Articles

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

Loretta S. Li, BS, Dezheng Huo, MS, Theodore Karrison, PhD, Richard A. Larson, MD, Olufunmilayo Olopade, MD

Blood (2004) 104 (11): 2018.

DOI: https://doi.org/10.1182/blood.V104.11.2018.2018

Published: 2004

Journal Articles

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Sonali M. Smith, Michelle M. Le Beau, Dezheng Huo, Theodore Karrison, Ronald M. Sobecks, John Anastasi, James W. Vardiman, Janet D. Rowley, Richard A. Larson

Blood (2003) 102 (1): 43–52.

DOI: https://doi.org/10.1182/blood-2002-11-3343

Published: 2003

NARROW

Final Results of Phase 1 MMRC Trial of Selinexor, Carfilzomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM)

Phase II Study of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas: Final Analysis of NCI 8309

Prospective Phase I Multi-Center Trial Incorporating Lenalidomide (LEN) into Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Patients with Double Hit (DHL) or Double Expressing (DEL) Lymphomas: Final Results

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Phase 1 MMRC Trial of Selinexor, Carfilzomib (CFZ), and Dexamethasone (DEX) in Relapsed and Relapsed/Refractory Multiple Myeloma (RRMM)

Haploinsufficiency of del(5q) genes, Egr1 and Apc , cooperate with Tp53 loss to induce acute myeloid leukemia in mice

Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc

Retroviral Insertional Mutagenesis In Egr1 +/- mice, Haploinsufficient For a Human Del(5q) Myeloid Leukemia Gene, Develop Myeloid Neoplasms With Proviral Insertions In Genes Syntenic To Human 5q

Identification of High Risk HLA Class I Amino Acid Substitutions in Hematopoietic Stem Cell Transplantation.

Therapy-Related Myeloid Neoplasms (t-MN) in 71 Patients Following Radiation Therapy (RT) Only,

Allogeneic Hematopoietic Cell Transplantation From Combined Haploidentical Family Members and Unrelated Cord Blood (CB) Can Benefit High Risk Patients Lacking HLA-Identical Donors.

Preliminary Results of Combined Haploidentical-Cord Blood Transplantation for Patients Lacking HLA Identical Donors

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only